[1] |
CAO Fei, YU Wenhao, TANG Xiaonan, MA Zidong, CHANG Tingmin, GONG Yabin, LIAO Mingjuan, KANG Xiaohong.
Mechanism of LINC01410 promoting proliferation and migration in esophageal squamous cell carcinoma
[J]. China Oncology, 2024, 34(8): 753-762.
|
[2] |
WANG Manli, CHEN Hui, DUAN Zhi, XU Qimei, LI Zhen.
A study on communication mechanism of lung cancer cells in tumor microenvironment mediated by pleckstrin-2/miR-196a signal axis
[J]. China Oncology, 2024, 34(7): 628-638.
|
[3] |
QIAN Bin, CHEN Haiquan.
Important progress in surgical treatment of lung cancer in 2023
[J]. China Oncology, 2024, 34(4): 335-339.
|
[4] |
LIN Yicong, WANG Yue, XUE Qianqian, ZHENG Qiang, JIN Yan, HUANG Ziling, LI Yuan.
Clinical pathological characteristics and immune microenvironment significance of EGFR T790M mutation in non-small cell lung cancer patients and its prognostic implications
[J]. China Oncology, 2024, 34(4): 368-379.
|
[5] |
JIANG Mengqi, HAN Yuchen, FU Xiaolong.
Research progress on H-E stained whole slide image analysis by artificial intelligence in lung cancer
[J]. China Oncology, 2024, 34(3): 306-315.
|
[6] |
XU Ziqi, HU Ruizhi, LI Junjian, WANG Hongxia, SANG Youzhou.
Exploring the role of methylation-driven gene IFFO1 in pancreatic adenocarcinoma diagnosis, prognosis and cellular functions
[J]. China Oncology, 2024, 34(11): 998-1010.
|
[7] |
WU Han, YANG Zhangru, FENG Wen, ZENG Wanqin, GUO Jindong, LI Hongxuan, WANG Changlu, WANG Jiaming, LÜ Changxing, ZHANG Qin, YU Wen, CAI Xuwei, FU Xiaolong.
The efficacy and prognosis analysis after stereotactic body radiotherapy for multiple primary early-stage lung cancer
[J]. China Oncology, 2023, 33(9): 844-856.
|
[8] |
JIA Liqing, GE Xiaolu, JIANG Lin, ZHOU Xiaoyan.
Effects of lncRNA PKD2-2-3 on cell proliferation, clone formation, migration, and invasion of lung adenocarcinoma
[J]. China Oncology, 2023, 33(8): 717-725.
|
[9] |
ZHANG Lingling, WANG Xiangyi, WEI Xing, LIN Li, TANG Chuanhao, LIANG Jun.
A study on prevention and treatment of chemotherapy induced nausea and vomiting in non-small cell lung cancer patients with low-frequency electrical stimulator for antiemesis
[J]. China Oncology, 2023, 33(8): 776-781.
|
[10] |
ZHANG Haoting, ZHENG Jing, FU Mengjiao, ZHOU Jianying.
Research progress on thyroid dysfunction induced by immunotherapy for lung cancer
[J]. China Oncology, 2023, 33(7): 701-706.
|
[11] |
ZHANG Pingchuan, DU Mingyu, YAO Chengyun, HE Xia, YIN Li.
Mechanism of circular RNA hsa_circ_0012779 expression in nasopharyngeal carcinoma and its influence on cell biological behavior
[J]. China Oncology, 2023, 33(5): 445-451.
|
[12] |
WU Jing, ZHOU Juan, SU Chunxia.
Advances in fatty acid metabolism reprogramming of lung cancer
[J]. China Oncology, 2023, 33(5): 517-526.
|
[13] |
SU Chunxia, ZHOU Caicun.
Important clinical research progress in lung cancer in 2022
[J]. China Oncology, 2023, 33(3): 218-227.
|
[14] |
FU Qingsheng, JIN Lei, ZHANG Xudong, XU Yingchen, ZHU Chunfu, QIN Xihu, WU Baoqiang.
Effect of tRF-Pro-CGG on the biological behavior of mouse pancreatic cancer cells and its molecular mechanism
[J]. China Oncology, 2023, 33(3): 241-249.
|
[15] |
ZOU Chunyuan, XU Xiaofeng, LU Renquan, GUO Lin.
Detection of p53, PGP9.5, SOX2, GAGE7, GBU4-5 and MAGE A1 protein levels in lung cancer tissues and peripheral blood and their clinical value
[J]. China Oncology, 2023, 33(1): 36-44.
|